A new study analyzed how a combination of atomoxetine and oxybutynin affects obstructive sleep apnea (OSA) severity. In this podcast, one of the study’s authors, Luigi Taranto-Montemurro, MD, from Harvard Medical School and Brigham and Women's Hospital, provides insight on his findings and what they mean for the future of pharmacotherapy for OSA. For more, click here: https://www.consultant360.com/pulmonology

Jonathan Spergel, MD, PhD, from Children’s Hospital of Philadelphia, discusses the current management of milk-induced eosinophilic esophagitis (EoE) among children, his study that evaluated epicutaneous immunotherapy as a potential treatment option, and more.

In this podcast, Christian Osadnik, PhD, discusses his team's latest research on the effects of pulmonary rehabilitation programs on comorbid depression and anxiety in patients with chronic obstructive pulmonary disease. More at: www.consultant360.com/pulmonology.

In this podcast, Paul Pasquina, MD, from the Uniformed Services University of the Health and Sciences, discusses the perspective of the Department of Defense regarding concussion, managing concussion and other traumatic brain injuries in military personnel, and the treatment options for individuals with concussion. More at: www.consultant360.com/neurology.

In this podcast, Robert P. Giugliano, MD, discusses the safety and efficacy findings from IMPROVE-IT, the practical implications for ezetimibe, and more. More at: www.consultant360.com/cardiology.

Nancy Desai, MD, from Boston Medical Center, discusses her research presented at the Annual European Congress of Rheumatology that explored the association between lupus, cervical cancer screening, and prevention, as well as why providers should educate patients on their risk of cervical dysplasia.

Alessio Fasano, MD, from Massachusetts General Hospital, discusses the need for more novel tools to perform better research on celiac disease, his research on a new 3-dimensional model for studying the effect of microbiota-derived molecules in celiac disease, and more.

In this podcast, Peter Reaven, MD, discusses the effects of glucose variability on vascular disease outcomes, the results of the ACCORD and VADT trials, and how the trials' results have impacted clinical practice over the years. More at: www.consultant360.com/cardiology.

Dr Wei discusses her latest research, which found that patients with a first-degree relative who has had melanoma have a higher risk of multiple types of skin cancer.

In this podcast, Cherinne Arundel, MD, and her colleague Phillip Lam, MD, discuss their latest research study about systolic blood pressure and outcomes in patients with heart failure with reduced ejection fraction. More at: www.consultant360.com/cardiology.